CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. (2020)
Attributed to:
University of Oxford Confidence in Concept Scheme – Round 5
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2020.00448
PubMed Identifier: 32309216
Publication URI: http://europepmc.org/abstract/MED/32309216
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in oncology
ISSN: 2234-943X